The SARS-CoV-2 Disease and the Risk of Transfusion Transmission: A Narrative Review

Emerging infection outbreaks have a deteriorating effect for the blood supply by limiting resources and compromising safety of transfusion products. The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) which leads to self-limited upper disease emerged from China turned into pandemic in January 2020. Symptomatic, asymptomatic recuperative patients can be reservoirs transmission but their viral load plasma, serum, or lymphocytes incubation period is not known, thus rate infectivity remains uncertain. Even though detected yet, solitary case has reported neonate born mother with coronavirus disease-2019 (COVID-19) elevated antibody levels abnormal cytokine test results 2 hours after birth, pointing at possibility vertical transmission. With spreading wider, number donations keeps rising, resulting transfusions COVID-19 SARS-CoV-2 free recipients. It stated that if all were tested RNA up 15% donors phase would excluded carrying RNA. Although data suggest it transmissible through no confirmed cases transmission, presence donated plasma still considered constitute risk both healthcare personnel Therefore, centers banks are advised take measure protection SARS-COV-2 avoid transfusion.